» Articles » PMID: 24690532

Characterization of the Classical Biological False-positive Reaction in the Serological Test for Syphilis in the Modern Era

Overview
Date 2014 Apr 3
PMID 24690532
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

To characterize the CBFP reaction in the modern era, we analyzed the results of parallel rapid plasma reagin (RPR) and Treponema pallidum particle agglutination (TPPA) tests from a total of 63,765 blood samples obtained at Zhongshan Hospital in the Medical College of Xiamen University from May 2008 to February 2013. Among the 63,765 tested blood samples, 206 (0.32%) had the CBFP reaction. In multivariate analysis, an increased likelihood of the CBFP reaction was associated with female subjects, subjects ≥80years old, and subjects between 16 and 35years old (P<0.05). The CBFP reaction occurred in association with 17 categories of disease, including 60 types of diseases, in the 206 subjects. To our knowledge, a number of these diseases had not been previously reported to be associated with the CBFP in the RPR test, including false labor, megaloblastic anemias, aplastic anemias, redundant prepuce, congenital malformation of heart, and salpingitis. Among the 206 patients with the CBFP reaction, 35 patients were subjected to follow-up for five years. 26 out of 35 these patients were at a 1:1 initial RPR titer, 8 out of 35 patients were at a 1:2 initial RPR titer, and 1 out of 35 patients were at a 1:4 initial RPR titer. 30 subjects had their RPR seroreverted. In our opinion, additional CBFP research using a large sample population will contribute to the identification of additional underlying serious disorders that are not related to syphilis. Such results could be useful for the prediction and diagnosis of these diseases.

Citing Articles

Clinical characteristics and cause analysis of false-positive results in treponemal testing among patients.

Wang W, Fan X, Zhou K, Chen Q, Huang X Ann Med. 2025; 57(1):2454327.

PMID: 39868671 PMC: 11774184. DOI: 10.1080/07853890.2025.2454327.


External quality assessment to support the WHO ProSPeRo study for the evaluation of two dual HIV/syphilis point-of-care tests in seven countries.

Cao W, Fakile Y, Shukla M, Pettus K, Lupoli K, Hong J BMC Infect Dis. 2024; 24(Suppl 1):194.

PMID: 38418989 PMC: 10902925. DOI: 10.1186/s12879-024-09027-3.


Trends of syphilis seroprevalence at a tertiary care center in New Delhi, India: A 10-year analysis.

Srivastava P, Bhargava A, Bansal S, Khunger N, Saxena A Indian J Sex Transm Dis AIDS. 2023; 44(1):20-23.

PMID: 37457516 PMC: 10343113. DOI: 10.4103/ijstd.ijstd_77_22.


Unspecific reactivity must be excluded in COVID-19 epidemiological analyses or virus tracing based on serologic testing: Analysis of 46,777 post-pandemic samples and 1,114 pre-pandemic samples.

Cai M, Lin J, Zhu J, Dai Z, Lin Y, Liang X Front Med (Lausanne). 2022; 9:1018578.

PMID: 36465910 PMC: 9708875. DOI: 10.3389/fmed.2022.1018578.


Which Is the Optimum Antigen Concentration for the Venereal Disease Research Laboratory Test of Cerebrospinal Fluid for Neurosyphilis Diagnosis: 10 or 17 μL?.

Xiao Y, Li W, Li Q, Xu Q, Yang Y, Yang T Front Med (Lausanne). 2022; 9:877186.

PMID: 35572962 PMC: 9095981. DOI: 10.3389/fmed.2022.877186.